메뉴 건너뛰기




Volumn 13, Issue 12, 2007, Pages 1703-1709

Delayed-onset primary cytomegalovirus disease after liver transplantation

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

EID: 37549071844     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21280     Document Type: Article
Times cited : (104)

References (33)
  • 1
    • 13144250735 scopus 로고    scopus 로고
    • Cytomegalovirus infection after solid organ transplantation
    • Bowden R, Ljungman P, Paya C, eds, Philadelphia, PA: Lippincott, Williams and Wilkins;
    • Paya C, Razonable RR. Cytomegalovirus infection after solid organ transplantation. In: Bowden R, Ljungman P, Paya C, eds. Transplant Infections. Vol 1. Philadelphia, PA: Lippincott, Williams and Wilkins; 2003:298-325.
    • (2003) Transplant Infections , vol.1 , pp. 298-325
    • Paya, C.1    Razonable, R.R.2
  • 2
    • 0031916426 scopus 로고    scopus 로고
    • Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation
    • de Otero J, Gavalda J, Murio E, Vargas V, Calico I, Llopart L, et al. Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation. Clin Infect Dis 1998;26:865-870.
    • (1998) Clin Infect Dis , vol.26 , pp. 865-870
    • de Otero, J.1    Gavalda, J.2    Murio, E.3    Vargas, V.4    Calico, I.5    Llopart, L.6
  • 3
    • 0036250743 scopus 로고    scopus 로고
    • Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C
    • Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002;8: 362-369.
    • (2002) Liver Transpl , vol.8 , pp. 362-369
    • Burak, K.W.1    Kremers, W.K.2    Batts, K.P.3    Wiesner, R.H.4    Rosen, C.B.5    Razonable, R.R.6
  • 4
    • 0030985417 scopus 로고    scopus 로고
    • Cytomegalovirus viremia: Risk factor for allograft cirrhosis after liver transplantation for hepatitis C
    • Rosen HR, Chou S, Corless CL, Gretch DR, Flora KD, Boudousquie A, et al. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997;64:721-726.
    • (1997) Transplantation , vol.64 , pp. 721-726
    • Rosen, H.R.1    Chou, S.2    Corless, C.L.3    Gretch, D.R.4    Flora, K.D.5    Boudousquie, A.6
  • 5
    • 0031058988 scopus 로고    scopus 로고
    • Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients
    • Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. Ann Intern Med 1997;126:275-279.
    • (1997) Ann Intern Med , vol.126 , pp. 275-279
    • Falagas, M.E.1    Snydman, D.R.2    Griffith, J.3    Ruthazer, R.4    Werner, B.G.5
  • 6
    • 0029947327 scopus 로고    scopus 로고
    • Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection
    • van den Berg AP, Klompmaker IJ, Haagsma EB, Peeters PM, Meerman L, Verwer R, et al. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. Clin Transplant 1996;10:224-231.
    • (1996) Clin Transplant , vol.10 , pp. 224-231
    • van den Berg, A.P.1    Klompmaker, I.J.2    Haagsma, E.B.3    Peeters, P.M.4    Meerman, L.5    Verwer, R.6
  • 7
    • 30444439103 scopus 로고    scopus 로고
    • Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation
    • Slifkin M, Ruthazer R, Freeman R, Bloom J, Fitzmaurice S, Fairchild R, et al. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation. Liver Transpl 2005;11:1597-1602.
    • (2005) Liver Transpl , vol.11 , pp. 1597-1602
    • Slifkin, M.1    Ruthazer, R.2    Freeman, R.3    Bloom, J.4    Fitzmaurice, S.5    Fairchild, R.6
  • 8
    • 26444437323 scopus 로고    scopus 로고
    • Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
    • Jain A, Orloff M, Kashyap R, Lansing K, Betts R, Mohanka R, et al. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients? Transplant Proc 2005;37: 3182-3186.
    • (2005) Transplant Proc , vol.37 , pp. 3182-3186
    • Jain, A.1    Orloff, M.2    Kashyap, R.3    Lansing, K.4    Betts, R.5    Mohanka, R.6
  • 11
    • 11144288655 scopus 로고    scopus 로고
    • Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients
    • Freeman RB, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, et al. Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients. Transplantation 2004;78:1765-1773.
    • (2004) Transplantation , vol.78 , pp. 1765-1773
    • Freeman, R.B.1    Paya, C.2    Pescovitz, M.D.3    Humar, A.4    Dominguez, E.5    Washburn, K.6
  • 12
    • 0035576910 scopus 로고    scopus 로고
    • Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir
    • Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, et al. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 2001; 184:1461-1464.
    • (2001) J Infect Dis , vol.184 , pp. 1461-1464
    • Razonable, R.R.1    Rivero, A.2    Rodriguez, A.3    Wilson, J.4    Daniels, J.5    Jenkins, G.6
  • 13
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
    • (1987) J Chronic Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    MacKenzie, C.R.4
  • 14
    • 16644369923 scopus 로고    scopus 로고
    • Cytomegalovirus
    • Cytomegalovirus. Am J Transplant 2004;4(suppl 10):51-58.
    • (2004) Am J Transplant , vol.4 , Issue.SUPPL. 10 , pp. 51-58
  • 15
    • 0037090071 scopus 로고    scopus 로고
    • Definitions of cytomegalovirus infection and disease in transplant recipients
    • Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094-1097.
    • (2002) Clin Infect Dis , vol.34 , pp. 1094-1097
    • Ljungman, P.1    Griffiths, P.2    Paya, C.3
  • 16
    • 1942469969 scopus 로고    scopus 로고
    • Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
    • Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004;4:611-620.
    • (2004) Am J Transplant , vol.4 , pp. 611-620
    • Paya, C.1    Humar, A.2    Dominguez, E.3    Washburn, K.4    Blumberg, E.5    Alexander, B.6
  • 17
    • 11144358263 scopus 로고    scopus 로고
    • Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R-solid organ transplant recipients
    • Humar A, Paya C, Pescovitz MD, Dominguez E, Washburn K, Blumberg E, et al. Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R-solid organ transplant recipients. Am J Transplant 2004; 4:644-649.
    • (2004) Am J Transplant , vol.4 , pp. 644-649
    • Humar, A.1    Paya, C.2    Pescovitz, M.D.3    Dominguez, E.4    Washburn, K.5    Blumberg, E.6
  • 18
    • 17444431146 scopus 로고    scopus 로고
    • Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients
    • Razonable RR. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Am J Health Syst Pharm 2005;62(suppl 1):S7-S13.
    • (2005) Am J Health Syst Pharm , vol.62 , Issue.SUPPL. 1
    • Razonable, R.R.1
  • 19
    • 31044456596 scopus 로고    scopus 로고
    • Primary cytomegalovirus disease after five years of antiviral prophylaxis
    • Kijpittayarit S, Deziel P, Eid AJ, Razonable RR. Primary cytomegalovirus disease after five years of antiviral prophylaxis. Transplantation 2006;81:137-138.
    • (2006) Transplantation , vol.81 , pp. 137-138
    • Kijpittayarit, S.1    Deziel, P.2    Eid, A.J.3    Razonable, R.R.4
  • 20
    • 0035892802 scopus 로고    scopus 로고
    • Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis
    • Boivin G, Gilbert C, Gaudreau A, Greenfield I, Sudlow R, Roberts NA. Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis. J Infect Dis 2001;184:1598-1602.
    • (2001) J Infect Dis , vol.184 , pp. 1598-1602
    • Boivin, G.1    Gilbert, C.2    Gaudreau, A.3    Greenfield, I.4    Sudlow, R.5    Roberts, N.A.6
  • 21
    • 0031659447 scopus 로고    scopus 로고
    • Estradiol enhances gene delivery to human breast tumor cells
    • Jain PT, Gewirtz DA. Estradiol enhances gene delivery to human breast tumor cells. J Mol Med 1998;76:709-714.
    • (1998) J Mol Med , vol.76 , pp. 709-714
    • Jain, P.T.1    Gewirtz, D.A.2
  • 22
    • 0032731673 scopus 로고    scopus 로고
    • Estradiol enhances liposome-mediated uptake, preferential nuclear accumulation and functional expression of exogenous genes in MDA-MB231 breast tumor cells
    • Jain PT, Seth P, Gewirtz DA. Estradiol enhances liposome-mediated uptake, preferential nuclear accumulation and functional expression of exogenous genes in MDA-MB231 breast tumor cells. Biochim Biophys Acta 1999;1451:224-232.
    • (1999) Biochim Biophys Acta , vol.1451 , pp. 224-232
    • Jain, P.T.1    Seth, P.2    Gewirtz, D.A.3
  • 24
    • 5644261372 scopus 로고    scopus 로고
    • Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation
    • Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, et al. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 2004;47:1550-1556.
    • (2004) Diabetologia , vol.47 , pp. 1550-1556
    • Hjelmesaeth, J.1    Sagedal, S.2    Hartmann, A.3    Rollag, H.4    Egeland, T.5    Hagen, M.6
  • 25
    • 33746423879 scopus 로고    scopus 로고
    • The natural course of cytomegalovirus infection and disease in renal transplant recipients
    • Hartmann A, Sagedal S, Hjelmesaeth J. The natural course of cytomegalovirus infection and disease in renal transplant recipients. Transplantation 2006;82(suppl): S15-S17.
    • (2006) Transplantation , vol.82 , Issue.SUPPL.
    • Hartmann, A.1    Sagedal, S.2    Hjelmesaeth, J.3
  • 26
    • 4744359046 scopus 로고    scopus 로고
    • Hafiz MM, Poggioli R, Caulfield A, Messinger S, Geiger MC, Baidal DA, et al. Cytomegalovirus prevalence and transmission after islet allograft transplant in patients with type 1 diabetes mellitus. Am J Transplant 2004;4:1697-1702.
    • Hafiz MM, Poggioli R, Caulfield A, Messinger S, Geiger MC, Baidal DA, et al. Cytomegalovirus prevalence and transmission after islet allograft transplant in patients with type 1 diabetes mellitus. Am J Transplant 2004;4:1697-1702.
  • 27
    • 0035128676 scopus 로고    scopus 로고
    • Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis
    • Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kisilisik AT, et al. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis 2001;3:8-15.
    • (2001) Transpl Infect Dis , vol.3 , pp. 8-15
    • Lo, A.1    Stratta, R.J.2    Egidi, M.F.3    Shokouh-Amiri, M.H.4    Grewal, H.P.5    Kisilisik, A.T.6
  • 28
    • 10744221396 scopus 로고    scopus 로고
    • Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation
    • Kaufman DB, Iii GW, Bruce DS, Johnson CP, Gaber AO, Sutherland DE, et al. Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. Am J Transplant 2003; 3:855-864.
    • (2003) Am J Transplant , vol.3 , pp. 855-864
    • Kaufman, D.B.1    Iii, G.W.2    Bruce, D.S.3    Johnson, C.P.4    Gaber, A.O.5    Sutherland, D.E.6
  • 30
    • 33746824548 scopus 로고    scopus 로고
    • Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation
    • Hellinger WC, Bonatti H, Machicao VI, Yao JD, Brumble LM, Alvarez S, et al. Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation. Mayo Clin Proc 2006;81: 1029-1033.
    • (2006) Mayo Clin Proc , vol.81 , pp. 1029-1033
    • Hellinger, W.C.1    Bonatti, H.2    Machicao, V.I.3    Yao, J.D.4    Brumble, L.M.5    Alvarez, S.6
  • 31
    • 20444453778 scopus 로고    scopus 로고
    • Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: A systematic review of randomised controlled trials
    • Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 2005;365:2105-2115.
    • (2005) Lancet , vol.365 , pp. 2105-2115
    • Hodson, E.M.1    Jones, C.A.2    Webster, A.C.3    Strippoli, G.F.4    Barclay, P.G.5    Kable, K.6
  • 33
    • 2942622305 scopus 로고    scopus 로고
    • Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: A collaborative transplant study report
    • Opelz G, Dohler B, Ruhenstroth A. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004;4:928-936.
    • (2004) Am J Transplant , vol.4 , pp. 928-936
    • Opelz, G.1    Dohler, B.2    Ruhenstroth, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.